on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Mural Oncology
The Vanguard Group, Inc. has filed a Form 8.3 relating to Mural Oncology plc. The disclosure, submitted under the Irish Takeover Panel Act, reveals The Vanguard Group holds a significant interest, with 772,885 ordinary shares representing 4.48% of Mural Oncology's relevant securities. The document indicates no additional disclosures for other parties involved in potential offers.
The record, dated 22 May 2025, specifies that there were sales of 36 shares at 2.75 USD per unit. No cash-settled or stock-settled derivative transactions were reported. Moreover, no new agreements, indemnities, or understandings relevant to securities dealings have been entered.
The disclosure is in compliance with Rule 8.3, requiring declarations by individuals with interests exceeding 1% in relevant securities of a company subject to takeover rules.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news